Keyword search (4,163 papers available)

"Egli M" Authored Publications:

Title Authors PubMed ID
1 DNA Replication across α-l-(3'-2')-Threofuranosyl Nucleotides Mediated by Human DNA Polymerase η Tomar R; Ghodke PP; Patra A; Smyth E; Pontarelli A; Copp W; Guengerich FP; Chaput JJ; Wilds CJ; Stone MP; Egli M; 39259676
CHEMBIOCHEM
2 Beyond ribose and phosphate: Selected nucleic acid modifications for structure-function investigations and therapeutic applications Liczner C; Duke K; Juneau G; Egli M; Wilds CJ; 33981365
CHEMBIOCHEM
3 Backbone Flexibility Influences Nucleotide Incorporation by Human Translesion DNA Polymerase η opposite Intrastrand Cross-Linked DNA. O'Flaherty DK, Guengerich FP, Egli M, Wilds CJ 26624500
CHEMBIOCHEM
4 Lesion Orientation of O4-Alkylthymidine Influences Replication by Human DNA Polymerase η. O'Flaherty DK, Patra A, Su Y, Guengerich FP, Egli M, Wilds CJ 27574558
CHEMBIOCHEM
5 O6-2'-Deoxyguanosine-butylene-O6-2'-deoxyguanosine DNA Interstrand Cross-Links Are Replication-Blocking and Mutagenic DNA Lesions. Xu W, Kool D, O'Flaherty DK, Keating AM, Sacre L, Egli M, Noronha A, Wilds CJ, Zhao L 27768841
CHEMBIOCHEM

 

Title:Beyond ribose and phosphate: Selected nucleic acid modifications for structure-function investigations and therapeutic applications
Authors:Liczner CDuke KJuneau GEgli MWilds CJ
Link:https://pubmed.ncbi.nlm.nih.gov/33981365/
DOI:10.3762/bjoc.17.76
Publication:Beilstein journal of organic chemistry
Keywords:antisensechemically modified oligonucleotidescrystallographysiRNAstructure
PMID:33981365 Category: Date Added:2021-05-19
Dept Affiliation: CHEMBIOCHEM
1 Department of Chemistry and Biochemistry, Concordia University, Montréal, Québec H4B 1R6, Canada.
2 Department of Biochemistry, Vanderbilt Institute of Chemical Biology, and Center for Structural Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232, United States.

Description:

Over the past 25 years, the acceleration of achievements in the development of oligonucleotide-based therapeutics has resulted in numerous new drugs making it to the market for the treatment of various diseases. Oligonucleotides with alterations to their scaffold, prepared with modified nucleosides and solid-phase synthesis, have yielded molecules with interesting biophysical properties that bind to their targets and are tolerated by the cellular machinery to elicit a therapeutic outcome. Structural techniques, such as crystallography, have provided insights to rationalize numerous properties including binding affinity, nuclease stability, and trends observed in the gene silencing. In this review, we discuss the chemistry, biophysical, and structural properties of a number of chemically modified oligonucleotides that have been explored for gene silencing.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University